این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
یکشنبه 30 آذر 1404
Tanaffos
، جلد ۲۲، شماره ۴، صفحات ۳۸۲-۳۸۸
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Interleukin-6 in COVID-19 Severity Stratification
چکیده انگلیسی مقاله
Background:
The increase in the number of patients with COVID-19 on a global scale made the early recognition of severe forms of the disease essential. Considering that IL-6 acts as a pro-inflammatory mediator, mediating acute phase responses, the objective of this study was to assess its value in the early severity stratification of SARS-CoV2 infection.
Materials and Methods:
It was a prospective study included IL-6 measurement in patients with SARS-CoV2 infection upon admission to the emergency department. Two groups were considered (Group I: patients without hospitalization criteria; Group II: patients with hospitalization criteria). Analyzed variables were serum levels of IL-6, C-reactive protein, ferritin, d-dimers, sociodemographics, ventilator support, ICU admission, mortality, dates of diagnosis, hospitalization, and discharge. For the statistical analyses, Mann-Whitney test, Pearson's chi-square test, area under the receiver operating characteristic curve, Youden index, and Spearman correlation were applied.
Results:
A total number of 117 patients were included. Mean age was significantly higher for group II (72,35±15,39 years; p<0,001). No statistically significant difference was seen between the groups regarding gender (p=0,111). The IL-6 values showed an excellent power of discrimination for the need for hospitalization (AUC=0,888; p<0,001) and the need for ICU admission (AUC=0,897; p=7.9 x 10-5). Also, its cut-off value of 12,4pg/mL for the need for hospitalization and 42,95 pg/mL for the need for ICU admission was determined. Positive correlation was seen between IL-6 value and length of stay [r(35)=0,380; p=0,020]. Three deaths were observed among patients with hospitalization criteria (8,1%).
Conclusion:
The value of IL-6 at admission seems to independently influence the probability of hospitalization (general ward or ICU) and its duration.
کلیدواژههای انگلیسی مقاله
COVID-19,Interleukin-6,SARS-CoV-2
نویسندگان مقاله
Fernando Pereira Da Silva |
Department of Pulmonology, Unidade Local de Saúde da Guarda, Avenida Rainha Dona Amélia 19, 6300-749, Guarda, Portugal
Maria Filomena Luís |
Department of Pulmonology, Unidade Local de Saúde da Guarda, Avenida Rainha Dona Amélia 19, 6300-749, Guarda, Portugal
Filipa Jesus |
Department of Pulmonology, Unidade Local de Saúde da Guarda, Avenida Rainha Dona Amélia 19, 6300-749, Guarda, Portugal
Joana Ribeiro |
Department of Pulmonology, Unidade Local de Saúde da Guarda, Avenida Rainha Dona Amélia 19, 6300-749, Guarda, Portugal
Elin Almeida |
Department of Pulmonology, Unidade Local de Saúde da Guarda, Avenida Rainha Dona Amélia 19, 6300-749, Guarda, Portugal
Sara Braga |
Department of Pulmonology, Unidade Local de Saúde da Guarda, Avenida Rainha Dona Amélia 19, 6300-749, Guarda, Portugal
Luís Ferreira |
Department of Pulmonology, Unidade Local de Saúde da Guarda, Avenida Rainha Dona Amélia 19, 6300-749, Guarda, Portugal
نشانی اینترنتی
https://www.tanaffosjournal.ir/article_714790_6447664d1a5332248b436b0fef82f7c9.pdf
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات